| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $4.55 | $3.97 | $4.88 | $4.85 | $3.81 | $0.89 | $0.85 | $0.80 |
| EPS (Diluted) | $4.54 | $3.95 | $4.86 | $4.83 | $3.80 | $0.89 | $0.84 | $0.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.2B | $23.1B | $23.1B | $21.9B | $20.9B | $19.0B | $18.1B | $16.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.6B |
| Total Liabilities | $21.3B | $20.2B | $20.3B | $19.5B | $18.4B | $16.6B | $15.8B | $14.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.9B | $2.8B | $2.7B | $2.5B | $2.4B | $2.4B | $2.3B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.4B | $0.5B | $0.3B | $0.3B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.9B | $0.2B | $-1.5B | $-1.8B | $-0.9B | $-0.2B | $-1.4B | $-1.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.9B | $-0.3B | $0.8B | $0.1B | $1.6B | $0.7B | $0.9B | $0.9B |